Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial

Objective A previous sham-controlled multinational study demonstrated the short-term efficacy and safety for xerostomia treatment of an intraoral device that delivers electrostimulation to the lingual nerve. The objective of this study was to test the hypothesis that those beneficial effects would b...

Full description

Autores:
Alajbeg, Iva
Falcào, Denise Pinheiro
tran, simon d
Martín-Granizo, Rafael A.
Lafaurie, Gloria Ines
Matranga, Domenica
Pejda, Slavica
Vuletic, Lea
Mantilla, Rubén Darío
Leal, Soraya Coelho
Barreto Bezerra, Ana Cristina
Ménard, Henri André
Kimoto, Suguru
Pan, Shaoxia
Maniegas, Lourdes
Krushinski, Cheryl A.
MELILLI, Dario
campisi, giuseppina
Paderni, Carlo
Bautista Mendoza, Gloria R.
Yepes, Juan Fernando
Lindh, Liselott
Koray, Meltem Ozar
Mumcu, Gonca
Elad, Sharon
zeevi, itai
Aldape Barrios, Beatriz Catalina
López Sánchez, Rodrigo M.
Lassauzay, Claire
Fromentin, Olivier
Beiski, Ben Z.
Strietzel, Frank
Konttinen, Yrjó Tapio
Wolff, Andy
Zunt, Susan L.
Tipo de recurso:
Article of journal
Fecha de publicación:
2012
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/3579
Acceso en línea:
http://hdl.handle.net/20.500.12495/3579
https://doi.org/10.1016/j.oooo.2012.01.012
https://repositorio.unbosque.edu.co
Palabra clave:
Xerostomía
Nervio lingual
Estimulación eléctrica transcutánea del nervio
Rights
openAccess
License
Acceso abierto
Description
Summary:Objective A previous sham-controlled multinational study demonstrated the short-term efficacy and safety for xerostomia treatment of an intraoral device that delivers electrostimulation to the lingual nerve. The objective of this study was to test the hypothesis that those beneficial effects would be sustained over an 11-month period. Study Design The device was tested on a mixed sample of 94 patients with xerostomia in an open-label, uncontrolled, prospective multicenter trial. Statutory outcome assessments were done at 5th, 8th, and 11th months and analyzed by multiple comparisons. Results Improvements achieved at month 5 from baseline were sustained throughout the follow-up period for the primary outcome, xerostomia severity, and the secondary outcomes resting whole salivary flow rate, xerostomia frequency, oral discomfort, and difficulties in speech, swallowing, and sleeping. No significant side effects were detected. Conclusions The beneficial effects of a removable intraoral electrostimulating device were sustained for an 11-month period.